You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API relugolix, estradiol hemihydrate, and norethindrone acetate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing relugolix, estradiol hemihydrate, and norethindrone acetate

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Sumitomo Pharma America Inc	MYFEMBREE	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415	FERRIC OXIDE YELLOW	2026-01-27
Sumitomo Pharma America Inc	MYFEMBREE	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415	HYDROXYPROPYL CELLULOSE	2026-01-27
Sumitomo Pharma America Inc	MYFEMBREE	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415	HYPROMELLOSE 2910	2026-01-27
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for relugolix, estradiol hemihydrate, and norethindrone acetate

Excipient focus: FERRIC OXIDE YELLOW

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2910

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing HYPROMELLOSE 2910

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing HYPROMELLOSE 2910

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing TRIACETIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing TRIACETIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.